Medreich is a fully integrated pharmaceutical company with an established presence across the globe. The company is involved in the CMO & CDMO business of pharmaceutical preparations in various dosage forms catering to diverse Therapeutic categories.
Medreich has an advanced state of the art Research and Development centre with proven scientific competence to develop formulations as Patent Non-infringing and Niche generics in differentiated dosage form for global regulated markets.
Medreich has in house capability to ensure regulatory compliance in regulated markets across the globe.
The company is manufacturing formulations in various dosage forms for MNC’s like GSK, Pfizer, Sanofi Aventis, Novartis, Mylan, Apotex, Adcock Ingram and many other customers across 55 countries in key markets of Europe, Australia & New Zealand, Canada, Japan, Far East Asia, GCC, Africa, LATAM and CIS.
With more than 3000 employees worldwide, Medreich is providing a strong platform to its employees to learn, contribute and grow and is committed to providing quality medicines to patients world over to make their lives healthier.
In the year 2015 Medreich achieved the transformational milestone in its 40 years of existence and became part of Meiji Group a leading Japanese conglomerate listed on Tokyo stock exchange and having business interests across the globe in Pharmaceuticals, food and nutrition products.
As we stretch ourselves globally, our success depends on the strengths of our local partnerships.
Winning together is about working together as a team focused on clearly agreed objectives.
What makes Medreich a winning company is its people power.